Muscle Stretching - the Potential Role of Endogenous Pain Inhibitory Modulation on Stretch Tolerance

October 19, 2018 updated by: Morten Pallisgaard, University College of Northern Denmark
This study investigates the influence of a remote, painful stimulus on stretch tolerance. Half of the participants will receive a conditioning painful stimulus following static stretching while the other half will rest quietly.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The effect of stretching on joint range of motion is primarily related to changes in the tolerance to stretch, but the mechanisms underlying this change are still largely unknown.

The nervous system has an inbuilt ability to modulate the perceived magnitude of afferent noxious stimuli via supraspinally mediated endogenous pain inhibition or facilitation and by engaging endogenous mechanisms pain tolerance in healthy individuals is known to increase. Thus increasing the tolerance to pain could potentially increase range of motion following stretching.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalborg, Denmark, 9220
        • University College of Northern Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Eligibility for participation included the absence of any pain or other conditions that might affect the somatosensory system.

Exclusion Criteria:

  • Substance abuse,
  • History of neurological or mental disabilities
  • Lack of ability to comply with instructions
  • Delayed onset of muscle soreness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental pain group
subjects in the pain group were instructed to immerse their non-dominant hand into a container with circulating water at 1˚C to 4˚C and keep it there for 2 minutes. They were instructed to immerse it to wrist-level and keep the hand open.
Participants placed their non-dominant hand into cold water for 2 minutes
No Intervention: Control group
Participants rested in a seated position for 5 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee extension range of motion
Time Frame: Passive knee extension range of motion was measured at baseline
Passively induced knee extension range of motion was measured usind the Biodex system 4 pro isokinetic dynomometer
Passive knee extension range of motion was measured at baseline
Change in knee extension range of motion between baseline and post stretch.
Time Frame: Changes in passive knee extension range of motion were measured 5 minutes after baseline measures following stretching
Changes in passively induced knee extension range of motion was measured using the Biodex system 4 pro isokinetic dynomometer
Changes in passive knee extension range of motion were measured 5 minutes after baseline measures following stretching
Changes in knee extension range of motion between post stretch and post pain.
Time Frame: Changes in passive knee extension range of motion were measured 5 minutes after post stretch measures following intervention.
Changes in passively induced knee extension range of motion was measured using the Biodex system 4 pro isokinetic dynomometer
Changes in passive knee extension range of motion were measured 5 minutes after post stretch measures following intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surface electromyography measures of muscle activity
Time Frame: Muscle activity during the passive knee extension motion was measured at baseline
Muscle activity during the passive knee extension motion were measured using SEMG.
Muscle activity during the passive knee extension motion was measured at baseline
Changes in surface electromyography measures of muscle activity between baseline and post stretch measures.
Time Frame: Changes in muscle activity during the passive knee extension motion were measured 5 minutes after baseline measures following stretching.
Changes in muscle activity during the passive knee extension motion were measured using SEMG.
Changes in muscle activity during the passive knee extension motion were measured 5 minutes after baseline measures following stretching.
Changes in surface electromyography measures of muscle activity between post stretch and post pain measures.
Time Frame: Changes in muscle activity during the passive knee extension motion were measured 5 minutes after post stretch measures following intervention.
Changes in muscle activity during the passive knee extension motion were measured using SEMG.
Changes in muscle activity during the passive knee extension motion were measured 5 minutes after post stretch measures following intervention.
Passive resistive torque using the Biodes system 4 pro.
Time Frame: Passive resistive torque during the passive knee extension motion was measured at baseline.
Passive resistive torque during the passive knee extension motion was measured using the Biodex system 4 pro isokinetic dynamometer.
Passive resistive torque during the passive knee extension motion was measured at baseline.
Changes in passive resistive torque measured using the Biodex system 4 pro between baseline and post stretch measures.
Time Frame: Changes in passive resistive torque during the passive knee extension motion was measured 5 minutes after baseline measures following stretching.
Changes in passive resistive torque during the passive knee extension motion was measured using the Biodex system 4 pro isokinetic dynamometer.
Changes in passive resistive torque during the passive knee extension motion was measured 5 minutes after baseline measures following stretching.
Changes in passive resistive torque measured using the Biodex system 4 pro between post stretch and post pain measures.
Time Frame: Passive resistive torque during the passive knee extension motion was measured 5 minutes after post stretch measures following intervention.
Changes in Passive resistive torque during the passive knee extension motion was measured using the Biodex system 4 pro isokinetic dynamometer.
Passive resistive torque during the passive knee extension motion was measured 5 minutes after post stretch measures following intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Dorte Drachman, Msc., University College of Northern Denmark, Department of Physiotherapy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

November 30, 2016

Study Completion (Actual)

November 30, 2016

Study Registration Dates

First Submitted

October 15, 2018

First Submitted That Met QC Criteria

October 19, 2018

First Posted (Actual)

October 22, 2018

Study Record Updates

Last Update Posted (Actual)

October 22, 2018

Last Update Submitted That Met QC Criteria

October 19, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • UniversityCND

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Stretching Exercises

Clinical Trials on Cold pressor test

3
Subscribe